{"AllianceGenome": "225", "HGNC": "225", "MIM": "146920", "_id": "103", "_version": 1, "accession": {"genomic": ["AF084517.1", "AF084518.1", "AH005822.2", "AL592078.10", "AL606500.8", "AL691488.3", "CH471121.2", "CP068277.2", "LC775144.1", "LC775145.1", "LC775146.1", "LC775147.1", "NC_000001.11", "NC_060925.1", "NG_011844.2", "U32571.1", "X98560.1"], "protein": ["AAB06697.1", "AAB97116.1", "AAB97117.1", "AAB97118.1", "AAC13782.1", "AAH38227.1", "ABM73519.1", "ABM73520.1", "AHZ44503.1", "BAD93128.1", "BAH14119.1", "CAA55967.1", "CAA55968.1", "CAA67169.1", "CAA67170.1", "CAA67172.1", "CAA67173.1", "CAD98075.1", "CAE45853.1", "EAW53183.1", "EAW53184.1", "EAW53185.1", "EAW53186.1", "EAW53187.1", "EAW53188.1", "EAW53189.1", "EAW53190.1", "NP_001020278.1", "NP_001102.3", "NP_001180424.1", "NP_001351974.1", "NP_001351975.1", "NP_001351976.1", "NP_001351977.1", "NP_001351978.1", "NP_056655.3", "NP_056656.3", "P55265.4", "XP_011507363.2", "XP_011507364.1", "XP_047284296.1", "XP_047284342.1", "XP_047284361.1", "XP_047284397.1", "XP_054189776.1", "XP_054189777.1", "XP_054189778.1", "XP_054189779.1", "XP_054189780.1", "XP_054189781.1"], "rna": ["AA449679.1", "AB209891.1", "AF084516.1", "AI309328.1", "AK097241.1", "AK304153.1", "BC017853.1", "BC038227.1", "BE886208.1", "BU430287.1", "BX538232.1", "BX640741.1", "CD108625.1", "CR982397.1", "DA507408.1", "DR158819.1", "EF190448.1", "EF190449.1", "EF190450.1", "EF190451.1", "EF190452.1", "EF190453.1", "KJ544856.1", "NM_001025107.3", "NM_001111.5", "NM_001193495.2", "NM_001365045.1", "NM_001365046.1", "NM_001365047.1", "NM_001365048.1", "NM_001365049.1", "NM_015840.4", "NM_015841.4", "U10439.1", "U18121.1", "X79448.1", "X79449.1", "X98559.1", "X98561.1", "X98562.1", "X98563.1", "XM_011509061.3", "XM_011509062.2", "XM_047428340.1", "XM_047428386.1", "XM_047428405.1", "XM_047428441.1", "XM_054333801.1", "XM_054333802.1", "XM_054333803.1", "XM_054333804.1", "XM_054333805.1", "XM_054333806.1"], "translation": [{"protein": "AHZ44503.1", "rna": "KJ544856.1"}, {"protein": "ABM73519.1", "rna": "EF190448.1"}, {"protein": "XP_011507364.1", "rna": "XM_011509062.2"}, {"protein": "BAH14119.1", "rna": "AK304153.1"}, {"protein": "XP_047284296.1", "rna": "XM_047428340.1"}, {"protein": "XP_054189776.1", "rna": "XM_054333801.1"}, {"protein": "XP_054189779.1", "rna": "XM_054333804.1"}, {"protein": "XP_054189780.1", "rna": "XM_054333805.1"}, {"protein": "NP_001102.3", "rna": "NM_001111.5"}, {"protein": "NP_001180424.1", "rna": "NM_001193495.2"}, {"protein": "XP_011507363.2", "rna": "XM_011509061.3"}, {"protein": "AAB06697.1", "rna": "U10439.1"}, {"protein": "NP_001351974.1", "rna": "NM_001365045.1"}, {"protein": "NP_056655.3", "rna": "NM_015840.4"}, {"protein": "NP_001351978.1", "rna": "NM_001365049.1"}, {"protein": "XP_054189778.1", "rna": "XM_054333803.1"}, {"protein": "NP_001351977.1", "rna": "NM_001365048.1"}, {"protein": "CAA67170.1", "rna": "X98559.1"}, {"protein": "XP_047284342.1", "rna": "XM_047428386.1"}, {"protein": "CAA67169.1", "rna": "X98559.1"}, {"protein": "XP_054189781.1", "rna": "XM_054333806.1"}, {"protein": "CAD98075.1", "rna": "BX538232.1"}, {"protein": "BAD93128.1", "rna": "AB209891.1"}, {"protein": "CAA67173.1", "rna": "X98562.1"}, {"protein": "CAA55968.1", "rna": "X79449.1"}, {"protein": "ABM73520.1", "rna": "EF190449.1"}, {"protein": "AAH38227.1", "rna": "BC038227.1"}, {"protein": "NP_001020278.1", "rna": "NM_001025107.3"}, {"protein": "NP_001351975.1", "rna": "NM_001365046.1"}, {"protein": "NP_001351976.1", "rna": "NM_001365047.1"}, {"protein": "XP_047284397.1", "rna": "XM_047428441.1"}, {"protein": "CAA55967.1", "rna": "X79448.1"}, {"protein": "NP_056656.3", "rna": "NM_015841.4"}, {"protein": "AAC13782.1", "rna": "U18121.1"}, {"protein": "XP_054189777.1", "rna": "XM_054333802.1"}, {"protein": "CAE45853.1", "rna": "BX640741.1"}, {"protein": "XP_047284361.1", "rna": "XM_047428405.1"}]}, "alias": ["ADAR1", "AGS6", "DRADA", "DSH", "DSRAD", "G1P1", "IFI-4", "IFI4", "K88DSRBP", "P136"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "definitive", "classification_date": "2024-01-05T17:00:00.000Z", "disease_label": "Aicardi-Goutieres syndrome", "gcep": "Brain Malformations Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0018866", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_9cf90ec8-f2fd-4b93-89ca-d20e628a6109-2024-01-05T170000.000Z", "sop": "SOP10"}, {"classification": "limited", "classification_date": "2020-08-27T16:46:42.352Z", "disease_label": "Leigh syndrome", "gcep": "Mitochondrial Diseases Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0009723", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03f538b5-43af-4699-9ddb-264077de21c9-2020-08-27T164642.352Z", "sop": "SOP7"}, {"classification": "definitive", "classification_date": "2024-04-29T19:00:00.000Z", "disease_label": "ADAR-related type 1 interferonopathy", "gcep": "Leukodystrophy and Leukoencephalopathy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0700261", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_c6e83262-29db-4535-a41b-8cb8549009bf-2024-04-29T190000.000Z", "sop": "SOP10"}]}, "ec": "3.5.4.37", "ensembl": {"gene": "ENSG00000160710", "protein": ["ENSP00000357456", "ENSP00000357459", "ENSP00000431794", "ENSP00000496896", "ENSP00000497210", "ENSP00000497386", "ENSP00000497434", "ENSP00000497555", "ENSP00000497790", "ENSP00000497793", "ENSP00000497932", "ENSP00000498137", "ENSP00000504883", "ENSP00000505532", "ENSP00000505887", "ENSP00000505996", "ENSP00000506234", "ENSP00000506312", "ENSP00000506606", "ENSP00000506666", "ENSP00000518924", "ENSP00000518926", "ENSP00000518927", "ENSP00000518928", "ENSP00000518929", "ENSP00000518930", "ENSP00000518931", "ENSP00000518932", "ENSP00000518933", "ENSP00000518934", "ENSP00000518935", "ENSP00000518936"], "transcript": ["ENST00000368471", "ENST00000368474", "ENST00000463920", "ENST00000471068", "ENST00000492630", "ENST00000494866", "ENST00000526905", "ENST00000529168", "ENST00000534279", "ENST00000647682", "ENST00000648231", "ENST00000648311", "ENST00000648714", "ENST00000648871", "ENST00000649021", "ENST00000649022", "ENST00000649042", "ENST00000649408", "ENST00000649724", "ENST00000649749", "ENST00000679375", "ENST00000679465", "ENST00000679805", "ENST00000679899", "ENST00000680270", "ENST00000680305", "ENST00000680472", "ENST00000681056", "ENST00000681235", "ENST00000681429", "ENST00000681683", "ENST00000681786", "ENST00000681901", "ENST00000713626", "ENST00000713628", "ENST00000713629", "ENST00000713630", "ENST00000713631", "ENST00000713632", "ENST00000713633", "ENST00000713634", "ENST00000713635"], "translation": [{"protein": "ENSP00000506606", "rna": "ENST00000681235"}, {"protein": "ENSP00000518924", "rna": "ENST00000713626"}, {"protein": "ENSP00000497434", "rna": "ENST00000648714"}, {"protein": "ENSP00000504883", "rna": "ENST00000681901"}, {"protein": "ENSP00000505996", "rna": "ENST00000679899"}, {"protein": "ENSP00000505887", "rna": "ENST00000679375"}, {"protein": "ENSP00000505532", "rna": "ENST00000680270"}, {"protein": "ENSP00000506234", "rna": "ENST00000681056"}, {"protein": "ENSP00000357459", "rna": "ENST00000368474"}, {"protein": "ENSP00000506312", "rna": "ENST00000680305"}, {"protein": "ENSP00000518926", "rna": "ENST00000713628"}, {"protein": "ENSP00000518927", "rna": "ENST00000713629"}, {"protein": "ENSP00000518928", "rna": "ENST00000713630"}, {"protein": "ENSP00000518929", "rna": "ENST00000713631"}, {"protein": "ENSP00000518930", "rna": "ENST00000713632"}, {"protein": "ENSP00000497555", "rna": "ENST00000648231"}, {"protein": "ENSP00000357456", "rna": "ENST00000368471"}, {"protein": "ENSP00000496896", "rna": "ENST00000649022"}, {"protein": "ENSP00000518931", "rna": "ENST00000713633"}, {"protein": "ENSP00000518932", "rna": "ENST00000713634"}, {"protein": "ENSP00000497386", "rna": "ENST00000649408"}, {"protein": "ENSP00000518933", "rna": "ENST00000713635"}, {"protein": "ENSP00000518934", "rna": "ENST00000526905"}, {"protein": "ENSP00000497790", "rna": "ENST00000649042"}, {"protein": "ENSP00000497210", "rna": "ENST00000649749"}, {"protein": "ENSP00000498137", "rna": "ENST00000648311"}, {"protein": "ENSP00000497932", "rna": "ENST00000649724"}, {"protein": "ENSP00000431794", "rna": "ENST00000529168"}, {"protein": "ENSP00000497793", "rna": "ENST00000648871"}, {"protein": "ENSP00000518935", "rna": "ENST00000471068"}, {"protein": "ENSP00000518936", "rna": "ENST00000494866"}, {"protein": "ENSP00000506666", "rna": "ENST00000681683"}], "type_of_gene": "protein_coding"}, "entrezgene": "103", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 33.836850092, "exp_mis": 423.433379168, "exp_syn": 179.787208824, "lof_z": 4.7403982617947, "mis_z": 3.00528520228802, "mu_lof": 2.47453622005e-06, "mu_mis": 3.7073800149e-05, "mu_syn": 1.54013827295e-05, "n_lof": 6.0, "n_mis": 297.0, "n_syn": 205.0, "p_li": 0.907595373477161, "p_null": 5.11707289327527e-08, "p_rec": 0.0924045753521101, "syn_z": -1.16571170591448}, "bp": 3681, "cds_end": 154580482, "cds_start": 154557281, "n_exons": 15, "nonpsych": {"exp_lof": 30.3242916162, "exp_mis": 382.946756755, "exp_syn": 162.423457197, "lof_z": 4.69475917212979, "mis_z": 3.27200677352981, "mu_lof": 2.47453622005e-06, "mu_mis": 3.7073800149e-05, "mu_syn": 1.54013827295e-05, "n_lof": 4.0, "n_mis": 256.0, "n_syn": 189.0, "p_li": 0.987928894415273, "p_null": 9.48383995595117e-09, "p_rec": 0.0120710961008872, "syn_z": -1.31291566332714}, "nontcga": {"exp_lof": 31.1005323702, "exp_mis": 389.529366696, "exp_syn": 165.374875594, "lof_z": 4.43997252982668, "mis_z": 3.01727127542613, "mu_lof": 2.47453622005e-06, "mu_mis": 3.7073800149e-05, "mu_syn": 1.54013827295e-05, "n_lof": 6.0, "n_mis": 270.0, "n_syn": 186.0, "p_li": 0.786170360130861, "p_null": 4.84464278769971e-07, "p_rec": 0.213829155404861, "syn_z": -1.01550842185196}, "transcript": "ENST00000368474.4"}, "exons": [{"cdsend": 154601756, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590183, 154590409], [154596804, 154596995], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602626], [154627854, 154627971]], "strand": -1, "transcript": "NM_001025107", "txend": 154627971, "txstart": 154582057}, {"cdsend": 154608006, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590183, 154590409], [154596804, 154596995], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602626], [154607991, 154608186]], "strand": -1, "transcript": "NM_001111", "txend": 154608186, "txstart": 154582057}, {"cdsend": 154601756, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590183, 154590409], [154596804, 154596995], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602626], [154606005, 154606253]], "strand": -1, "transcript": "NM_001193495", "txend": 154606253, "txstart": 154582057}, {"cdsend": 154627995, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590183, 154590409], [154596804, 154596995], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602626], [154627953, 154627997]], "strand": -1, "transcript": "NM_001365045", "txend": 154627997, "txstart": 154582057}, {"cdsend": 154601756, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590183, 154590409], [154596804, 154596995], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602248], [154602384, 154602626], [154627953, 154627997]], "strand": -1, "transcript": "NM_001365046", "txend": 154627997, "txstart": 154582057}, {"cdsend": 154601756, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590183, 154590409], [154596804, 154596995], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602248], [154602384, 154602626], [154607991, 154608186]], "strand": -1, "transcript": "NM_001365047", "txend": 154608186, "txstart": 154582057}, {"cdsend": 154601756, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590183, 154590409], [154596804, 154596995], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602626], [154608750, 154608797]], "strand": -1, "transcript": "NM_001365048", "txend": 154608797, "txstart": 154582057}, {"cdsend": 154601756, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590261, 154590409], [154596804, 154596995], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602248], [154602384, 154602626], [154607991, 154608186]], "strand": -1, "transcript": "NM_001365049", "txend": 154608186, "txstart": 154582057}, {"cdsend": 154608006, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590261, 154590409], [154596804, 154596995], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602626], [154607991, 154608186]], "strand": -1, "transcript": "NM_015840", "txend": 154608186, "txstart": 154582057}, {"cdsend": 154608006, "cdsstart": 154584805, "chr": "1", "position": [[154582057, 154585043], [154585216, 154585344], [154585752, 154585865], [154586180, 154586363], [154588124, 154588258], [154588550, 154588673], [154589368, 154589462], [154589756, 154589928], [154590261, 154590409], [154596804, 154596938], [154597122, 154597267], [154597827, 154597976], [154598401, 154598585], [154601040, 154602626], [154607991, 154608186]], "strand": -1, "transcript": "NM_015841", "txend": 154608186, "txstart": 154582057}], "exons_hg19": [{"cdsend": 154574232, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562659, 154562885], [154569280, 154569471], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154575102], [154600330, 154600447]], "strand": -1, "transcript": "NM_001025107", "txend": 154600447, "txstart": 154554533}, {"cdsend": 154580482, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562659, 154562885], [154569280, 154569471], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154575102], [154580467, 154580662]], "strand": -1, "transcript": "NM_001111", "txend": 154580662, "txstart": 154554533}, {"cdsend": 154574232, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562659, 154562885], [154569280, 154569471], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154575102], [154578481, 154578729]], "strand": -1, "transcript": "NM_001193495", "txend": 154578729, "txstart": 154554533}, {"cdsend": 154600471, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562659, 154562885], [154569280, 154569471], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154575102], [154600429, 154600473]], "strand": -1, "transcript": "NM_001365045", "txend": 154600473, "txstart": 154554533}, {"cdsend": 154574232, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562659, 154562885], [154569280, 154569471], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154574724], [154574860, 154575102], [154600429, 154600473]], "strand": -1, "transcript": "NM_001365046", "txend": 154600473, "txstart": 154554533}, {"cdsend": 154574232, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562659, 154562885], [154569280, 154569471], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154574724], [154574860, 154575102], [154580467, 154580662]], "strand": -1, "transcript": "NM_001365047", "txend": 154580662, "txstart": 154554533}, {"cdsend": 154574232, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562659, 154562885], [154569280, 154569471], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154575102], [154581226, 154581273]], "strand": -1, "transcript": "NM_001365048", "txend": 154581273, "txstart": 154554533}, {"cdsend": 154574232, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562737, 154562885], [154569280, 154569471], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154574724], [154574860, 154575102], [154580467, 154580662]], "strand": -1, "transcript": "NM_001365049", "txend": 154580662, "txstart": 154554533}, {"cdsend": 154580482, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562737, 154562885], [154569280, 154569471], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154575102], [154580467, 154580662]], "strand": -1, "transcript": "NM_015840", "txend": 154580662, "txstart": 154554533}, {"cdsend": 154580482, "cdsstart": 154557281, "chr": "1", "position": [[154554533, 154557519], [154557692, 154557820], [154558228, 154558341], [154558656, 154558839], [154560600, 154560734], [154561026, 154561149], [154561844, 154561938], [154562232, 154562404], [154562737, 154562885], [154569280, 154569414], [154569598, 154569743], [154570303, 154570452], [154570877, 154571061], [154573516, 154575102], [154580467, 154580662]], "strand": -1, "transcript": "NM_015841", "txend": 154580662, "txstart": 154554533}], "generif": [{"pubmed": 11752786, "text": "crystallization and diffraction results when complexed with a chimeric oligonucleotide"}, {"pubmed": 11907222, "text": "overexpression inhibits HDV RNA replication and compromises virus viabiltiy"}, {"pubmed": 12243919, "text": "Up-regulation of type I interferon inducible 150kDa ADAR1 is associated with induction of A to G transcript mutations in systemic lupus erythematosus (SLE) T lymphocytes."}, {"pubmed": 12396729, "text": "The IFN-inducible RNA-specific adenosine deaminase ADAR1 promoter possesses a KCS-like (KCS-l) element."}, {"pubmed": 12414985, "text": "ADAR1 is primarily responsible for editing HDV RNA at the amber/W site during HDV infection."}, {"pubmed": 12429827, "text": "Results identify regions in human adenosine deaminase that acts on RNA (ADAR1) that interfere with nuclear localization and mediate cytoplasmic accumulation."}, {"pubmed": 12447867, "text": "Observational study of gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 12453429, "text": "ADAR1 has a role in protein translation independent of RNA editing"}, {"pubmed": 12916015, "text": "mutations involved in causing dyschromatosis symmetrica hereditaria have been identified in the gene that encodes double-stranded RNA-specific adenosine deaminase (DSRAD) as the disease gene"}, {"pubmed": 12954622, "text": "ADAR1 variants are differentially regulated during acute inflammation: the localization of these variants and of A-to-I RNA editing in the cytoplasm, nucleus, and nucleolus is intracellularly reorganized in response to inflammatory stimulation"}, {"pubmed": 14711814, "text": "the intracellular distribution of the various ADAR1 isoforms is determined by NLS-c, NES, NoLS, and a regulatory motif"}, {"pubmed": 15102079, "text": "This is the first report on DSRAD as the causative gene of dyschromatosis symmetrica hereditaria in the Chinese population."}, {"pubmed": 15146470, "text": "data add new variants to the repertoire of ADAR mutations in Dyschromatosis symmetrica hereditaria"}, {"pubmed": 15342791, "text": "Atomic force microscopy imaging of the Zalpha domain of ADAR1 complexed with supercoiled plasmid Z-DNA."}, {"pubmed": 15659327, "text": "R1155W missense mutation is a new mutation in exon 15 of DSRAD, the pathogenic gene of dyschromatosis symmetrica hereditaria"}, {"pubmed": 15724015, "text": "Frame-shift mutations in the DSRAD gene could cause dyschromatosis symmetrica hereditaria in the chinese population."}, {"pubmed": 15955093, "text": "We report 16 novel mutations containing six missense substitutions, two splice site mutations, six frameshift mutations, and two nonsense mutations found in Japanese patients with dyschromatosis symmetrica hereditaria."}, {"pubmed": 16055709, "text": "ADAR1 has the potential both to change information content through editing of mRNA and to regulate gene expression through interacting with NF90"}, {"pubmed": 16133458, "text": "Identification of a deletion mutation in the ADAR gene of a Chinese family with Dyschromatosis symmetrica hereditaria is reported."}, {"pubmed": 16475990, "text": "induction of ADAR1-L may at least partially cause the antiviral effect of IFN-alpha in natural immune response to HDV as well as in case of therapeutic administration of IFN"}, {"pubmed": 16886895, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16917490, "text": "10 novel mutations responsible for dyschromatosis symmetrica hereditaria: p.Q102fsX123, p.T369fsX374, p.S664fsX677, p.R892L, p.I913R, p.R916Q, p.P990fsX1016, p.C1081S, p.C1169F, and p.K1187X."}, {"pubmed": 17020943, "text": "ADAR1-L induces mutations in the viral RNA which leads to a loss of viral protein function and reduced viral infectivity, and contributes to the innate antiviral immune response."}, {"pubmed": 17021765, "text": "reports two novel mutations c.2116 G > A (E706K) and c.2848 C > T (Q950X) in the DSRAD gene identified in two Chinese pedigrees with DSH"}, {"pubmed": 17033168, "text": "Missense mutation of the double-stranded RNA-specific adenosine deaminase gene is associated with dyschromatosis symmetrica hereditaria"}, {"pubmed": 17079286, "text": "ADAR1 interacts with dsRNA-activated protein kinase PKR, inhibits its kinase activity, and suppresses the alpha subunit of eukaryotic initiation factor 2 (eIF-2alpha) phosphorylation, and thus increases host susceptibility to viral infection."}, {"pubmed": 17225010, "text": "5 families and 3 sporadic patients with dyschromatosis symmetrica hereditaria in a Chinese Han population were studied. By direct sequencing, 5 novel ADAR gene mutations and 3 mutations described previously were identified, all were heterozygous."}, {"pubmed": 17478391, "text": "Novel deletion mutation of gene in a Chinese family with Dyschromatosis Symmetrica Hereditaria"}, {"pubmed": 17569068, "text": "G to A mutation at the position 3,125 in exon 12 of the DSRAD gene induces a R1042H change in the putative deaminase domain of DSRAD. This, among other DSRAD mutations, is characteristic to dyschromatosis symmetrica hereditaria"}, {"pubmed": 17680540, "text": "A deletion mutation (c.2447G > A) in the ADAR gene has been detected in this in a pedigree with dyschromatosis symmetrical hereditar, which is probably one of the molecular bases of the pathogenesis of the disease."}, {"pubmed": 18178553, "text": "elevated levels of ADAR1, as found in astrocytomas, do indeed interfere with ADAR2 specific editing activity, and the endogenous ADAR1 can form heterodimers with ADAR2 in astrocytes"}, {"pubmed": 18243666, "text": "Six novel mutations of the ADAR1 gene are reported in Chinese patients with dyschromatosis symmetrica hereditaria."}, {"pubmed": 18362360, "text": "suggests a regulatory pathway by a combination of ADAR1 A-to-I editing enzyme and RNA degradation presumably with the aid of hUpf1"}, {"pubmed": 18422172, "text": "ADAR1 mRNA is expressed broadly in larynx carcinoma."}, {"pubmed": 18627385, "text": "The mutation is a novel heterozygous nucleotide T-->C transition at position 3617 in exon 15 of the DSRAD gene, which induces a M1206T change in the putative deaminase domain of DSRAD."}, {"pubmed": 18705826, "text": "histological findings in dyschromatosis symmetrica hereditaria mainly induced by the ADAR1 gene mutations."}, {"pubmed": 18753201, "text": "These data suggested the role of ADAR in modulation of HIV-1 replication."}, {"pubmed": 18799292, "text": "Four novel mutations of the ADAR1 gene have been reported in patients with dyschromatosis symmetrica hereditaria."}, {"pubmed": 18835380, "text": "Overexpressed ADAR1 specifically edits a yet unknown cellular substrate, which in turn affects plasmid-based gene expression."}, {"pubmed": 19124606, "text": "dsRBD3 in ADAR1 can mediate nuclear import, while interaction of all dsRBDs might control nuclear export."}, {"pubmed": 19434718, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19559055, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19605474, "text": "two interferon-induced proteins, ADAR1 and PKR, have antagonistic functions on HIV production"}, {"pubmed": 19637911, "text": "The data support an active B-Z transition mechanism in which the Z alpha(ADAR1) protein first binds to B-DNA and then converts it to left-handed Z-DNA, a conformation that is then stabilized by the additional binding of a second Z alpha(ADAR1) molecule."}, {"pubmed": 19667218, "text": "Observational study and genome-wide association study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19710021, "text": "the antiapoptotic activity of ADAR1 is achieved through suppression of activation of proapoptotic and double-stranded RNA-dependent activities, as exemplified by PKR and IRF-3."}, {"pubmed": 19713932, "text": "Results imply that ADAR1 and ADAR2 have biological functions as RNA-binding proteins that extend beyond editing per se and that even genomically encoded ADARs that are catalytically inactive may have such functions."}, {"pubmed": 19733181, "text": "Results indicate that the ADAR1 deaminase increases exogenous gene expression at the translational level by decreasing PKR-dependent eIF-2alpha phosphorylation."}, {"pubmed": 19913273, "text": "genetic knockdown results in increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following IFN treatment"}, {"pubmed": 20069304, "text": "Report novel missense mutations in DSRAD in Chinese families with dyschromatosis symmetrica hereditaria."}, {"pubmed": 20186421, "text": "mutations are associated with dyschromatosis symmetrica hereditaria"}, {"pubmed": 20300939, "text": "muation are associated with dyschromatosis symmetrica hereditaria"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20430589, "text": "four novel and two recurrent mutations of the ADAR1 gene in Chinese patients with dyschromatosis symmetrica hereditaria"}, {"pubmed": 20439151, "text": "5 novel mutations found in ADA1 gene in dyschromatosis symmetrical hereditaria in Japan"}, {"pubmed": 20586835, "text": "In conclusion, we have reported an insertion-deletion mutation of ADAR1 involved in dyschromatosis symmetrica hereditaria."}, {"pubmed": 20588308, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20708476, "text": "in a Chinese family with dyschromatosis symmetrica hereditaria, a frameshift mutation 767delA (p.H256fs-260X) in exon 2 was found in all affected members but not in the healthy individuals or the 60 unrelated controls"}, {"pubmed": 20802353, "text": "These data indicate that ADAR1 could play a role in the pathophysiology of suicide in patients with major depression."}, {"pubmed": 20805743, "text": "Type 1 diabetes subjects show a highly significant increase of ACP1*A/ADA1*2 gametic type compared with healthy subjects from the same population (P = 0.003)."}, {"pubmed": 20844743, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20875819, "text": "Studies indicate that ADAR1 (ZalphaADAR1) preferentially binds Z-DNA rather than B-DNA with high binding affinity."}, {"pubmed": 20931541, "text": "A missense mutation in the ADAR1 gene was associated with the pathogenesis of the dyschromatosis symmetrical hereditaria."}, {"pubmed": 21083709, "text": "Two novel splice site mutations of the ADAR1 gene in Chinese families with dyschromatosis symmetrica hereditaria"}, {"pubmed": 21159878, "text": "ADAR-1 hyperdeaminate adenosine residues in both measles virus and influenza virus A genomes."}, {"pubmed": 21217697, "text": "the Z-DNA- and Z-RNA-binding domain Zalpha, derived from the human RNA editing enzyme ADAR1-L, binds with high stability to specific rRNA segments of Escherichia coli and human ribosomes."}, {"pubmed": 21269755, "text": "investigation of plasma activity of total ADA, ADA1, and ADA2 in menses, follicular, and luteal phases of menstrual cycle: significant correlation between monocyte number and ADA activities"}, {"pubmed": 21301145, "text": "A joint study by NECS, SICS, JCS amd AJCS indicated relationship between ADAR and longevity.[review]"}, {"pubmed": 21316340, "text": "These results demonstrated that ADAR1 isoforms showed different expression patterns, suggesting that they might play different roles in pediatric leukemias."}, {"pubmed": 21490091, "text": "ADAR1 enhances replication of RNA viruses through two mechanisms: RNA editing and inhibition of RNA-activated protein kinase (PKR)."}, {"pubmed": 21587236, "text": "The editing sites of ADAR1 or ADAR2 in dsRNA are dictated by the catalytic domain."}, {"pubmed": 21924887, "text": "ADAR1 acts as a suppressor of PKR and displays proviral properties. (Review)"}, {"pubmed": 21933234, "text": "Two aberrant splice products were confirmed with RT-PCR and DNA direct sequence analysis; these novel findings further extend our understanding of the role of ADAR1 in dyschromatosis symmetrica."}, {"pubmed": 22022963, "text": "ADAR1 and not ADAR2 is required for cell survival. [review]"}, {"pubmed": 22039911, "text": "The novel c.1615delG (p.V539fs) mutation was found in the affected members but not in the healthy individuals in family 1 and the novel c.ins1372-9 CCACAGAT (p.D458fs) mutation was found in patients but not in the healthy members of family 2."}, {"pubmed": 22077581, "text": "identified three novel heterozygous mutations in the ADAR1 gene in dyschromatosis symmetrica hereditaria"}, {"pubmed": 22278222, "text": "ADAR1 suppresses the induction of interferon beta triggered by measles virus infection."}, {"pubmed": 22336994, "text": "Eleven novel mutations of the ADAR1 gene have been found in dyschromatosis symmetrica hereditaria."}, {"pubmed": 22821605, "text": "study reports a novel splice site mutation in the ADAR1 gene that is associated with dyschromatosis symmetrica hereditaria, long hair of the forearms, hypo/hyperpigmented hair, and dental anomalies in the affected individuals - a father and his two children"}, {"pubmed": 22843049, "text": "A novel DSRAD mutation in several members of a Chinese family expands the gene mutations associated with dyschromatosis symmetrica hereditaria."}, {"pubmed": 22885375, "text": "Investigatation of structure/activity relationships between ADAR1 and ADAR2 indicates that ADAR1 is more dependent than ADAR2 on the presence of N7 in the edited base."}, {"pubmed": 22974014, "text": "More than 100 mutations of ADAR1 have been reported in patients with dyschromatosis symmetrica hereditaria [review]."}, {"pubmed": 22993189, "text": "ADAR-1 massively edits HTLV-2 and STLV-3 retroviruses in vitro, but probably remains a rare phenomenon in vivo."}, {"pubmed": 23001123, "text": "we show that mutations in ADAR1 (also known as ADAR) cause the autoimmune disorder Aicardi-Goutieres syndrome (AGS)."}, {"pubmed": 23075647, "text": "we have found 2 novel and 1 recurrent mutation, which will expand the database of ADAR1 gene mutations in dyschromatosis symmetrica hereditaria (DSH) and may provide new insight into the pathogenesis of DSH."}, {"pubmed": 23079620, "text": "This study reveals that Zalpha(ADAR1) initially binds to d(CGCGCG)(2) through the distinct conformation, especially in the unusually flexible beta1-loop-alpha2 region, from the d(CGCGCG)(2)-(Zalpha(ADAR1))(2) complex."}, {"pubmed": 23115276, "text": "Measles virus-induced stress granule formation was PKR dependent but impaired by ADAR1."}, {"pubmed": 23275297, "text": "functional serial transplantation and shRNA studies demonstrate that ADAR1 knockdown impaired in vivo self-renewal capacity of blast crisis CML progenitors"}, {"pubmed": 23315877, "text": "Novel dominant ADAR1 mutation was identified in Chinese family with dyschromatosis symmetrica hereditaria."}, {"pubmed": 23336285, "text": "We reported four novel mutations in the ADAR1 genes of dyschromatosis symmetrica hereditaria patients."}, {"pubmed": 23474544, "text": "Our global analysis reveals that ADAR plays a major role in splicing regulation."}, {"pubmed": 23621649, "text": "The deaminase domain is important for ADAR1 function."}, {"pubmed": 23728176, "text": "Cancer cells silence ADAR1 by overexpressing miR-17 and miR-432, which both directly target the ADAR1 transcript."}, {"pubmed": 23766440, "text": "Findings highlight the fact that the differentially expressed ADARs in tumours, which are responsible for an A to I RNA editing imbalance, have great prognostic value and diagnostic potential for hepatocellular carcinoma."}, {"pubmed": 23853584, "text": "Data suggest that ADAR1 is a pro-viral host factor favoring replication of influenza A virus and dengue virus; viral proteins (influenza A virus NS1 and NS2; dengue virus NS3) appear to control ADAR1 activity."}, {"pubmed": 24065641, "text": "This finding improves our understanding of the role of ADAR1 in Dyschromatosis symmetrica hereditaria"}, {"pubmed": 24067935, "text": "ADAR1 regulates the expression of ARHGAP26 through A-to-I RNA editing by disrupting the binding of miR-30b-3p and miR-573 within the 3' UTR of ARHGAP26."}, {"pubmed": 24183664, "text": "These findings extend the role of ADAR and show that it cooperates with other RNA-processing proteins to regulate the sequence and expression of transcripts in human cells."}, {"pubmed": 24192045, "text": "Taken together, our results imply a role for ADAR1 in the regulation of pluripotency induction as well as in the maintenance of early iPSC properties."}, {"pubmed": 24256817, "text": "We then review the more recent findings about the impact of ADAR-mediated activity on the miRNA pathway in terms of biogenesis, target recognition, and gene expression regulation."}, {"pubmed": 24262145, "text": "ADAR1-related bilateral striatal necrosis/dystonia is associated with the presence of an interferon signature."}, {"pubmed": 24302582, "text": "Our findings reveal that altered gene-specific A-to-I editing events mediated by ADAR1 drive the development of ESCC, with potential implications in diagnosis, prognosis, and treatment of this disease."}, {"pubmed": 24351124, "text": "A functional polymorphism in ADAR1 gene affects HBsAg seroclearance both spontaneously and interferon induced."}, {"pubmed": 24433377, "text": "we found a novel nonsense mutation, which will further expand the spectrum of ADAR1 mutations involved in dyschromatosis symmetrica hereditaria."}, {"pubmed": 24440912, "text": "Findings uncover a critical link of ADAR1 to myogenesis, and further highlight an epigenetic mechanism by which ADAR1 and miR-1/206 interplay to control scheduled myoblast-myotube transition."}, {"pubmed": 24446047, "text": "Two novel DSRAD mutations, p.G1047D and p.Y587C, were found in Chinese patients with DSH and our data add new variants to the knowledge of DSRAD mutations in DSH."}, {"pubmed": 24753571, "text": "ADAR1 carries a unique nuclear localization signal (NLS) that overlaps one of its double-stranded RNA-binding domains (dsRBDs). This dsRBD-NLS is recognized by nuclear import receptor transportin 1 (also called karyopherin-beta2) in an RNA-sensitive manner."}, {"pubmed": 24813121, "text": "The binding of Z-DNA binding domain of human ADAR1 to the G-quadruplex in c-Myc promoter resulted in repression of c-Myc expression."}, {"pubmed": 24905200, "text": "The Adenosine deaminase acting on RNA1 catalyzes the C6 deamination of adenosine (A) to produce inosine (I) in regions of RNA with double-stranded (ds) character."}, {"pubmed": 24928581, "text": "among three RNA editing enzymes, only ADAR1 was overexpressed in primary esophageal squamous cell carcinoma compared with matched non-tumor specimens"}, {"pubmed": 24950769, "text": "Results identified novel and recurrent mutations of the ADAR1 gene in Chinese families with Dyschromatosis symmetrica hereditaria and demonstrated the importance of exonic nucleotides at exon-intron junctions for RNA splicing."}, {"pubmed": 25010446, "text": "NMR experiments on complexes of various ZalphaADAR1 mutants with a 6-bp DNA duplex"}, {"pubmed": 25172485, "text": "Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs."}, {"pubmed": 25344900, "text": "Use molecular dynamics simulation to examine binding mechanism between ADAR1 and Z-DNA."}, {"pubmed": 25389016, "text": "This study demonstrates that two interferon stimulated genes, i.e. PKR and ADAR1 have opposite effects on HTLV replication in vivo."}, {"pubmed": 25456137, "text": "ADAR1 mutations causing Aicardi-Goutieres syndrome affect the activity of the interferon-inducible cytoplasmic isoform more severely than the nuclear isoform."}, {"pubmed": 25468572, "text": "To the best of our knowledge, this is the first report of an ADAR mutation in a Korean family with dyschromatosis symmetrica hereditaria."}, {"pubmed": 25673044, "text": "Therefore, the expression of ADAR1 and ADAR2 was analyzed in chordoma tissues. It was found that ADAR1 was significantly overexpressed, which was accompanied by enhanced pre-miR-10a and pri-miR-125a A-to-I editing"}, {"pubmed": 25692240, "text": "Data show that a large fraction of the edited genes are positively correlated ADAR (ADAR1) and ADARB1 (ADAR2)."}, {"pubmed": 25708366, "text": "These findings reveal that ADAR1, but not its editing activity, is critical for hESC differentiation and neural induction by regulating miRNA biogenesis via direct RNA interaction."}, {"pubmed": 25751603, "text": "Genomic analysis of ADAR1 binding reveals its involvement in multiple RNA processing pathways."}, {"pubmed": 25763870, "text": "A novel mutation in exome 8 of ADAR1 was identified (c.2633-2634delCT) in all the affected members of family 1 (Fig. 1h). A novel mutation in exome 2 of ADAR1 was also identified (c.1057-1058delTG) in all the affected members of family 2 (Fig. 2f). These two mutations were not reported before and not found in the unaffected individuals of the families and 100 unrelated Chinese controls"}, {"pubmed": 25972541, "text": "Measles virus defective interfering RNAs are generated in the absence of C protein and can be destabilized by host ADAR1."}, {"pubmed": 25982145, "text": "In conclusion, we have found ten novel mutations in the ADAR1 of 7 dyschromatosis symmetrica hereditaria pedigrees and 3 sporadic individuals."}, {"pubmed": 26037352, "text": "The frameshift mutation of ADAR1 gene (c.2252insG) is associated with dyschromatosis symmetrica hereditaria."}, {"pubmed": 26047657, "text": "Data show that the protein levels of polypyrimidine tract binding protein 1 (PTBP1) and adenosine deaminase RNA-specific binding protein ADAR1 were cooperatively expressed in glioma tissues and cells."}, {"pubmed": 26084202, "text": "The function of primary RNA editing enzyme ADAR1 in pluripotent stem cells was investigated and found that loss of ADAR1 in human iPS cells promotes caspase3-mediated cell death."}, {"pubmed": 26335850, "text": "transcriptional activation of Adar1 by IFN occurs in the absence of STAT1 by a non-canonical STAT2-dependent pathway in mouse but not human cells."}, {"pubmed": 26338962, "text": "ADAR1, in an editing-independent manner, regulates the biogenesis of miR-222 at the transcription level and thereby ICAM1 expression, which consequently affects melanoma immune resistance."}, {"pubmed": 26363218, "text": "our data originally support the evidence that ADAR1 can be part of the cell protein array uploaded in HIV-1 particles."}, {"pubmed": 26485095, "text": "These findings suggest that adenosine deaminase acting on RNA 1 is subject to different regulations by DNA methyltransferase and histone deacetylase enzymes in neuronal SH-SY5Y cells."}, {"pubmed": 26640150, "text": "a role for ADAR1 as a lung cancer oncogene undergoing gene amplification-associated activation that affects downstream RNA editing patterns and patient prognosis."}, {"pubmed": 26655226, "text": "A-to-I RNA editing levels catalyzed by ADAR1 and ADARB1 decreased in Alzheimer's disease patients' brain tissues, mainly in the hippocampus and to a lesser degree in the temporal and frontal lobes."}, {"pubmed": 26658668, "text": "Recent research has demonstrated that inosine in the epitranscriptome and ADAR1 protein establish innate immune tolerance for host dsRNA formed by endogenous sequences."}, {"pubmed": 26817845, "text": "ADAR1 p150 as the major A-to-I editor in mouse embryo fibroblasts."}, {"pubmed": 26892242, "text": "A three-generation family exhibiting phenotypic variability with a single germline ADAR1 mutation suggests that chilblain might aggravate the clinical phenotypes of dyschromatosis symmetrica hereditaria."}, {"pubmed": 27060309, "text": "The frame-shift mutation c.2638delG and the nonsense mutation c.2867C>A in the ADAR1 gene are associated with the dyschromatosis symmetrica hereditaria."}, {"pubmed": 27104882, "text": "The molecular effects of ADAR1 overexpression in HEK293T cells by label-free quantitative proteomics has been reported."}, {"pubmed": 27230815, "text": "we have identified two novel mutations of the ADAR1 gene and explored their implications on the structure and functions of ADAR1 protein."}, {"pubmed": 27292188, "text": "Lentiviral ADAR1 wild-type, but not an editing-defective ADAR1(E912A) mutant, induces self-renewal gene expression and impairs biogenesis of stem cell regulatory let-7 microRNAs."}, {"pubmed": 27595325, "text": "In endothelial cells, ADAR1 overexpression induces CTSS RNA editing and consequently increases cathepsin S expression. ADAR1 levels and the extent of CTSS RNA editing are associated with changes in cathepsin S levels in patients with atherosclerotic vascular diseases."}, {"pubmed": 27643693, "text": "This study reviewed that Neurologic Phenotypes Associated with Mutations in ADAR1 in patients with Aicardi-Goutieres Syndrome."}, {"pubmed": 27658966, "text": "ADAR1 restricts LINE-1 retrotransposition."}, {"pubmed": 27729454, "text": "both lysine 574 and 576 are essential for ADAR1-P110 ubiquitination."}, {"pubmed": 27863387, "text": "ADAR1 contributes to gastric cancer development and progression via activating mTOR/p70S6K/S6 ribosomal protein signaling axis."}, {"pubmed": 28109322, "text": "Results indicated that ADAR1 might play an important role in the occurrence, progression and prognosis of cervical squamous cancer"}, {"pubmed": 28167698, "text": "It was established in this report that interactions between PACT, ADAR1 and HIV-1-encoded Tat protein diminish the activation of PKR in response to HIV-1 infection."}, {"pubmed": 28199207, "text": "discuss the function of ADAR1 and its regulatory role in viral infection, and establish the relationship between ADAR1 and virus-associated sepsis (review)"}, {"pubmed": 28278381, "text": "Editing in the STAT3 intron is performed by ADAR1 and affects STAT3 alternative splicing. RNA editing is one of the molecular mechanisms regulating the expression of STAT3beta."}, {"pubmed": 28362255, "text": "These results demonstrate that ablation of RNase L activity promotes survival of ADAR1 deficient cells even in the presence of MDA5 and MAVS, suggesting that the RNase L system is the primary sensor pathway for endogenous dsRNA that leads to cell death."}, {"pubmed": 28393185, "text": "the present study performed a mutation analysis of the ADAR1 gene in two sporadic patients with typical DSH from birth, and identified two novel mutations."}, {"pubmed": 28398248, "text": "Studies suggest that the overexpression of ADAR1 protein forms a feedback loop starting with a decreased microRNA miR-17-5p level, that in turn up-regulates ADAR1."}, {"pubmed": 28436945, "text": "ADAR1p110 isoform competitively inhibits binding of Staufen1 to the 3'-untranslated-region dsRNAs and antagonizes Staufen1-mediated mRNA decay."}, {"pubmed": 28527816, "text": "ADAR1 is targeted by miR-143 to regulate IL-1beta-induced HUVEC activation"}, {"pubmed": 28542129, "text": "These results extended the known functions of ADAR1 and RNA editing to the critical fine-tuning of the intracellular apoptotic signaling and also provided mechanistic explanation for ADAR1's roles in development and tumorigenesis."}, {"pubmed": 28561207, "text": "Study investigated genetic, phenotypic, and interferon status of 46 patients from 37 families with neurological disease due to mutations in ADAR1. Phenotype encompassed a spectrum of Aicardi-Goutieres syndrome, isolated bilateral striatal necrosis, spastic paraparesis with normal neuroimaging, a progressive spastic dystonic motor disorder, and adult-onset psychological difficulties with intracranial calcification."}, {"pubmed": 28640667, "text": "A novel function of ADAR1 as an inhibitor of L1 retrotransposition was demonstrated."}, {"pubmed": 28714361, "text": "the activation of the JAK/STAT pathway is a regulatory mechanism of ADAR1 expression and causes abnormal RNA editing profile in esophageal squamous cell carcinoma. This mechanism may serve as a new target for esophageal squamous cell carcinoma therapy"}, {"pubmed": 28913566, "text": "The range of human disease associated with ADAR1 mutations may extend further to include other inflammatory conditions while ADAR2 mutations may affect psychiatric conditions."}, {"pubmed": 28924040, "text": "These findings suggest that Zalpha domain of human ADAR1 binding with the GAC hairpin stem in COMP can lead to a non-genetic, RNA editing-mediated substitution in COMP that may then play a crucial role in the development of pseudoachondroplasia."}, {"pubmed": 28928239, "text": "The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK."}, {"pubmed": 28960389, "text": "ADAR1 functions other than RNA editing are reviewed."}, {"pubmed": 29018269, "text": "ADAR1 polymorphisms protected against severe liver disease in HIV/HCV-coinfected patients."}, {"pubmed": 29022489, "text": "We detected high ADAR1 expression in half of the triple-negative breast cancer patients. In addition to DNA mutations, RNA editing can be related to neoantigens; hence, we need to explore non-synonymous mutations exclusively found using RNA sequencing data to identify clinically relevant neoantigens."}, {"pubmed": 29030706, "text": "Results implicate rare variants in the Aicardi-Goutieres syndrome genes ADAR and RNASEH2B and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis, consistent with a genetic basis underlying inflammation-driven malignant transformation in glioma and prostate carcinoma development."}, {"pubmed": 29045406, "text": "The miRNAs that were found upregulated in DENV-infected cells did not control the production of infectious virus particles. On the other hand, miR-3614-5p, which was upregulated in DENV-negative macrophages, reduced DENV infectivity and regulated ADAR1 expression, a protein that facilitates viral replication."}, {"pubmed": 29129909, "text": "ADAR1 silencing resulted in a lower global double-stranded to single-stranded RNA ratio, suggesting that A-to-I editing can stabilize a large subset of imperfect RNA duplexes.  The results imply that the editing effect on RNA secondary structure is context dependent and underline the intricate regulatory role of ADAR1 on global RNA secondary structure."}, {"pubmed": 29144509, "text": "Data collected from our center strongly suggest that ADAR1 expression can effectively predict HCC patients' prognosis and an abnormal overexpression of ADAR1 is positively correlated with AR in HCC."}, {"pubmed": 29185800, "text": "Expansion of mutation spectrum in dyschromatosis symmetrica hereditaria by identifying eight novel ADAR1 mutations."}, {"pubmed": 29203771, "text": "Expression of wild-type, but not mutant, ADAR1 enhances Alu-dependent editing and transcriptional activity of GLI1, a Hedgehog (Hh) pathway transcriptional activator and self-renewal agonist, and promotes immunomodulatory drug resistance in vitro."}, {"pubmed": 29273356, "text": "ADAR copy number is negatively associated with apoptosis and several immune cell types' signatures."}, {"pubmed": 29321362, "text": "n this study, we found that a 28 year-old male patient harbouring a deleterious substitution of Leu1052Pro in the ADAR1 gene in a typical Dyschromatosis symmetrica hereditaria family. His mother suffered from the Dyschromatosis symmetrica hereditaria also owns the same mutation."}, {"pubmed": 29395325, "text": "ADAR1 knockout neuronal progenitor cells exhibited MDA5 (dsRNA sensor)-dependent spontaneous interferon production, PKR activation, and cell death. Thus, human ADAR1 regulates sensing of self versus nonself RNA, allowing pathogen detection while avoiding autoinflammation."}, {"pubmed": 29457714, "text": "high-throughput mutagenesis analysis (Sat-FACS-Seq) of conserved residues in an RNA-binding loop of hADAR1d revealed essential amino acids for function, advancing our understanding of RNA recognition by this domain"}, {"pubmed": 29536976, "text": "Four novel ADAR1 mutations were identified in Chinese pedigrees with dyschromatosis symmetrica hereditaria."}, {"pubmed": 29625900, "text": "ADAR1 promotes viral replication by acting as an RNA sensing inhibitor, by editing viral RNA and by inhibiting PKR."}, {"pubmed": 29637273, "text": "Changes in expression levels of ADAR1 and ADAR2 may represent an important regulatory mechanism in idiopathic pulmonary fibrosis, by regulating the processing of key miRNAs such as miRNA-21."}, {"pubmed": 29691780, "text": "ADAR1 regulates post-transcriptional gene expression in gastric cancer through both RNA editing-dependent and editing-independent mechanisms."}, {"pubmed": 29775506, "text": "This is the first reported DSH case with chilblains, harbouring a novel heterozygous in-frame deletion mutation of the third dsRBD in ADAR1."}, {"pubmed": 29855470, "text": "The adenosine deaminase RNA-specific binding protein (ADAR1)-dependent and RNA-editing-independent regulation of invasion, mediated by Integrin beta3 (ITGB3) suggests a central involvement of ADAR1 in cancer progression and metastasis."}, {"pubmed": 29896739, "text": "The c.3463C>T missense mutation of the ADAR1 gene probably underlies the dyschromatosis symmetrical hereditaria in the Chinese pedigree."}, {"pubmed": 29906476, "text": "Here, the authors describe ADAR1 role as a regulator of innate and antiviral immune function in hepatitis C virus infection, both in vitro and in patients. Polymorphisms within ADAR1 gene were found significantly associated to poor clinical outcome to hepatitis C therapy and advanced liver fibrosis in a cohort of hepatitis C virus and HIV-1 coinfected patients."}, {"pubmed": 29950133, "text": "This study investigates the genome-wide binding preferences of the nuclear constitutive isoforms ADAR1-p110 and ADAR2 on human miRNA species by RNA immunoprecipitation of ADAR-bound small RNAs ."}, {"pubmed": 29996118, "text": "CDK13 RNA over-editing sites mediated by ADAR1 may serve as novel cancer driver events in HCC progression."}, {"pubmed": 30061158, "text": "The multiple myeloma transcriptome is aberrantly hyperedited because of the overexpression of ADAR1. These events were associated with patients' survival independent of 1q21 amplifications and could affect patients' responsiveness to different treatment regimes."}, {"pubmed": 30192643, "text": "From a practical point, a view of our results suggest that smokers carrying both ADA1*2 and ADA2*2 alleles have a higher risk of hypertension."}, {"pubmed": 30290838, "text": "We confirmed the role of ADAR1 in this regulation using a shRNA in a breast cancer cell line (ZR-75-1). Altogether, these results revealed a significant association between the mRNA editing in genes related to cancer-relevant pathways and clinical outcomes, suggesting an important role of ADAR1 expression and function in breast cancer."}, {"pubmed": 30304469, "text": "the interplay of the Zalpha domain from ADAR1 and MBD3 may regulate the transition of the DNA conformation between B- and Z-DNA and thereby modulate chromatin accessibility, resulting in alterations in gene expression"}, {"pubmed": 30489667, "text": "Higher expression of ADAR1 into the cytoplasm resulted to be an independent prognostic factor"}, {"pubmed": 30559422, "text": "tumor-derived IFN resulting in chronic signaling creates a cellular state primed to respond to dsRNA accumulation, rendering Interferon stimulated gene-positive tumors susceptible to ADAR loss."}, {"pubmed": 30563560, "text": "AZIN1 RNA editing levels and ADAR1 expression were significantly elevated in gastric cancer tissues compared with matched normal mucosa."}, {"pubmed": 30573948, "text": "ADAR1 regulated endothelial cell survival which was mediated by FGFR2/PI3K/Akt pathway."}, {"pubmed": 30575730, "text": "essential gene for the survival of a subset of lung cancer cell lineswhich possess a high interferon gene expression signature"}, {"pubmed": 30583079, "text": "High ADAR1 expression is associated with invasive potential of cancer-associated fibroblasts in colorectal cancer."}, {"pubmed": 30590609, "text": "Stably introduced into cancer cell lines, the system reports on elevated endogenous ADAR1 editing activity induced by interferon as well as knockdown of ADAR1 and ADAR2. In a single-well setup we used the reporter in HeLa cells to screen a small molecule library of 33 000 compounds"}, {"pubmed": 30651363, "text": "In addition to serving as a PKR inhibitor, OV20.0 might modulate ADAR1-dependent gene expression."}, {"pubmed": 30737359, "text": "tRNA deamination by ADAT requires substrate-specific recognition mechanisms and can be inhibited by terminal restriction fragments."}, {"pubmed": 30798327, "text": "DAR1 p110 could strongly enhance the adhesion of HCC tumor cells to ECM, which was usually regarded as the initiation of tumor invasion. Such phenotype was caused due to up-regulation of ITGA2 both in mRNA and protein level."}, {"pubmed": 30948460, "text": "ADAR1-HIF-1alpha axis as a hitherto unrecognized key regulator in hypoxia."}, {"pubmed": 31033705, "text": "The ADAR1 edits endogenous RNA and reshapes its secondary structure, preventing MDA5 from perceiving the cells own RNA as pathogenic."}, {"pubmed": 31039163, "text": "Strong downregulation of ADAR2 and increase in ADAR1 expression was observed in blood samples from congenital heart disease (CHD) patients."}, {"pubmed": 31095429, "text": "AKT-1, -2, and -3 interact with both ADAR1p110 and ADAR2 and phosphorylate these RNA editases. Using site-directed mutagenesis of suspected AKT phosphorylation sites, AKT was found to primarily phosphorylate ADAR1p110 and ADAR2 on T738 and T553, respectively, and overexpression of the phosphomimic mutants ADAR1p110 (T738D) and ADAR2 (T553D) resulted in a 50-100% reduction in editase activity."}, {"pubmed": 31270214, "text": "adenosine deaminase acting on RNA 1 (ADAR1) and ADAR2, which catalyze adenosine-to-inosine RNA editing, downregulate the expression of constitutive androstane receptor (CAR) in human liver-derived cells by attenuating splicing"}, {"pubmed": 31315644, "text": "ADAR1 was overexpressed in oral squamous cell carcinoma (OSCC) and significantly associated with poor patient survival as well as the migration, invasion, EMT and stemness of OSCC. Mechanistically, ADAR1 was physically associated with Dicer, and six OSCC-associated oncogenic miRNAs were increased in OSCC cells with ADAR1 overexpression."}, {"pubmed": 31320745, "text": "Mendelian disease caused by variants affecting recognition of Z-DNA and Z-RNA by the Zalpha domain of the double-stranded RNA editing enzyme ADAR."}, {"pubmed": 31366735, "text": "Decreases in endogenous ADAR1 expression by knock-down or knock-out increased HBV RNA levels. A major hepatocyte-specific microRNA, miRNA-122, was found to be positively correlated with ADAR1 expression, and exogenous miRNA-122 decreased both HBV RNA and DNA, whereas, conversely, transfection with a miRNA-122 inhibitor increased them."}, {"pubmed": 31413087, "text": "IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification."}, {"pubmed": 31413531, "text": "Study found that MEG3 expression was indeed a factor affecting the prognosis of colorectal cancer (CRC) patients, and that patients with high levels of MEG3 had a remarkably higher overall survival rate. lncRNA MEG3 is down-regulated in CRC and blood level of MEG3 serves as diagnostic and prognostic marker in CRC. MEG3 regulates cell function by targeting ADAR1 in CRC."}, {"pubmed": 31585913, "text": "ADAR1 promotes HBV replication through its deaminase domain."}, {"pubmed": 31636123, "text": "work identifies ADAR1 as a proviral factor involved in ZIKV replication, suggesting that ADAR1 could be a potential antiviral target."}, {"pubmed": 31733589, "text": "Recognition of DNA adducts by edited and unedited forms of DNA glycosylase NEIL1."}, {"pubmed": 31772029, "text": "Cardiac valve involvement in ADAR-related type I interferonopathy."}, {"pubmed": 31882741, "text": "ADAR1 function affects HPV replication and is associated to recurrent human papillomavirus-induced dysplasia in HIV coinfected individuals."}, {"pubmed": 31959472, "text": "ADAR1p150 regulates the biosynthesis and function of miRNA-149* in human melanoma."}, {"pubmed": 32034135, "text": "ADAR1 edits an intronic splicing silencer, leading to recruitment of SRSF7 and repression of exon inclusion."}, {"pubmed": 32046435, "text": "Aberrant Overexpression of RNA-Editing Enzyme ADAR1 Promotes the Progression of Endometriosis."}, {"pubmed": 32157211, "text": "ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity."}, {"pubmed": 32203492, "text": "We also observe a dominance of long-range interactions within ADAR substrates and analyze differences between ADAR1 and ADAR2 editing substrates. Moreover, we unexpectedly discovered that ADAR proteins bind dsRNA substrates tandemly in vivo, each with a 50-bp footprint."}, {"pubmed": 32275931, "text": "ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response."}, {"pubmed": 32307643, "text": "Urogenital Abnormalities in Adenosine Deaminase Deficiency."}, {"pubmed": 32348766, "text": "ADAR1 Facilitates KSHV Lytic Reactivation by Modulating the RLR-Dependent Signaling Pathway."}, {"pubmed": 32410589, "text": "ADAR expression and copy number variation in patients with advanced gastric cancer."}, {"pubmed": 32433965, "text": "Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing."}, {"pubmed": 32593192, "text": "Mutation analyses of patients with dyschromatosis symmetrica hereditaria: five novel mutations of the ADAR1 gene."}, {"pubmed": 32603639, "text": "What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs."}, {"pubmed": 32898178, "text": "The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection."}, {"pubmed": 32911246, "text": "Movement disorders in ADAR1 disease: Insights from a comprehensive cohort."}, {"pubmed": 33046702, "text": "High-throughput mutagenesis reveals unique structural features of human ADAR1."}, {"pubmed": 33110236, "text": "Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer."}, {"pubmed": 33179227, "text": "[Analysis of ADAR1 gene variants in two pedigrees affected with dyschromatosis symmetrica hereditaria]."}, {"pubmed": 33245772, "text": "Dual conformational recognition by Z-DNA binding protein is important for the B-Z transition process."}, {"pubmed": 33265998, "text": "The ADAR Family in Amphioxus: RNA Editing and Conserved Orthologous Site Predictions."}, {"pubmed": 33289110, "text": "Co-occurrence of Aicardi-Goutieres syndrome type 6 and dyschromatosis symmetrica hereditaria due to compound heterozygous pathogenic variants in ADAR1: a case series from India."}, {"pubmed": 33383047, "text": "Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis."}, {"pubmed": 33509238, "text": "ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism."}, {"pubmed": 33515843, "text": "Adenosine deaminases acting on RNA modulate the expression of the human pregnane X receptor."}, {"pubmed": 33542240, "text": "Recognition of non-CpG repeats in Alu and ribosomal RNAs by the Z-RNA binding domain of ADAR1 induces A-Z junctions."}, {"pubmed": 33712600, "text": "ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells."}, {"pubmed": 33736931, "text": "ADAR RNA Modifications, the Epitranscriptome and Innate Immunity."}, {"pubmed": 33781748, "text": "RNA editing enzyme ADAR1 governs the circadian expression of P-glycoprotein in human renal cells by regulating alternative splicing of the ABCB1 gene."}, {"pubmed": 33905683, "text": "Deciphering the principles of the RNA editing code via large-scale systematic probing."}, {"pubmed": 33972779, "text": "Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence."}, {"pubmed": 34297039, "text": "ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses."}, {"pubmed": 34319598, "text": "RNA editing enzyme adenosine deaminases acting on RNA 1 deficiency increases the sensitivity of non-small cell lung cancer cells to anlotinib by regulating CX3CR1-fractalkine expression."}, {"pubmed": 34343497, "text": "Protein kinase R and the integrated stress response drive immunopathology caused by mutations in the RNA deaminase ADAR1."}, {"pubmed": 34346762, "text": "Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing."}, {"pubmed": 34380029, "text": "ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation."}, {"pubmed": 34482352, "text": "Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virus."}, {"pubmed": 34496885, "text": "An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks."}, {"pubmed": 34624571, "text": "Conformational exchange of the Zalpha domain of human RNA editing enzyme ADAR1 studied by NMR spectroscopy."}, {"pubmed": 34768866, "text": "Deciphering the Biological Significance of ADAR1-Z-RNA Interactions."}, {"pubmed": 35052382, "text": "Detection of A-to-I RNA Editing in SARS-COV-2."}, {"pubmed": 35064076, "text": "Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2."}, {"pubmed": 35122924, "text": "Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells."}, {"pubmed": 35202641, "text": "The RNA editing enzyme ADAR modulated by the rs1127317 genetic variant diminishes EGFR-TKIs efficiency in advanced lung adenocarcinoma."}, {"pubmed": 35459560, "text": "ADAR1 and its implications in cancer development and treatment."}, {"pubmed": 35614224, "text": "ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis."}, {"pubmed": 35697535, "text": "ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer."}, {"pubmed": 35731225, "text": "Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells."}, {"pubmed": 35753353, "text": "RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells."}, {"pubmed": 35859175, "text": "ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation."}, {"pubmed": 35935998, "text": "IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation."}, {"pubmed": 36012303, "text": "ADAR1 Isoforms Regulate Let-7d Processing in Idiopathic Pulmonary Fibrosis."}, {"pubmed": 36077054, "text": "RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis."}, {"pubmed": 36243986, "text": "ADAR activation by inducing a syn conformation at guanosine adjacent to an editing site."}, {"pubmed": 36252997, "text": "Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization."}, {"pubmed": 36518246, "text": "ADAR1-dependent editing regulates human beta cell transcriptome diversity during inflammation."}, {"pubmed": 36577155, "text": "ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation."}, {"pubmed": 36683360, "text": "Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC."}, {"pubmed": 36710220, "text": "ADAR1 and ZBP1 in innate immunity, cell death, and disease."}, {"pubmed": 36747029, "text": "ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer."}, {"pubmed": 36865502, "text": "A Comprehensive and Systematic Analysis Revealed the Role of ADAR1 in Pan-Cancer Prognosis and Immune Implications."}, {"pubmed": 36921992, "text": "RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN."}, {"pubmed": 36959226, "text": "ADAR1 has an oncogenic function and can be a prognostic factor in cervical cancer."}, {"pubmed": 37162299, "text": "ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma."}, {"pubmed": 37208334, "text": "ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer."}, {"pubmed": 37209819, "text": "RNA editing of AZIN1 coding sites is catalyzed by ADAR1 p150 after splicing."}, {"pubmed": 37217676, "text": "ADAR1 polymorphisms contribute to increased susceptibility in pediatric acute lymphoblastic leukemia."}, {"pubmed": 37221310, "text": "Identification of novel interacts partners of ADAR1 enzyme mediating the oncogenic process in aggressive breast cancer."}, {"pubmed": 37414093, "text": "Clinical significance, tumor immune landscape and immunotherapy responses of ADAR in pan-cancer and its association with proliferation and metastasis of bladder cancer."}, {"pubmed": 37740860, "text": "Multi-dimensional Insight into the Coexistence of Pathogenic Genes for ADAR1 and TSC2: Careful Consideration is Essential for Interpretation of ADAR1 Variants."}, {"pubmed": 37831098, "text": "ADAR1 links R-loop homeostasis to ATR activation in replication stress response."}, {"pubmed": 38052548, "text": "Elevated ADAR expression is significantly linked to shorter overall survival and immune infiltration in patients with lung adenocarcinoma."}, {"pubmed": 38169584, "text": "ADAR1 protects pulmonary macrophages from sepsis-induced pyroptosis and lung injury through miR-21/A20 signaling."}, {"pubmed": 38176170, "text": "ADAR-mediated RNA editing regulates PVR immune checkpoint in colorectal cancer."}, {"pubmed": 38190734, "text": "Impact of Disease-Associated Mutations on the Deaminase Activity of ADAR1."}, {"pubmed": 38265938, "text": "Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing."}, {"pubmed": 38530197, "text": "Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells."}, {"pubmed": 38531645, "text": "Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity."}, {"pubmed": 38684307, "text": "[Analysis of ADAR gene variants in a Chinese pedigree affected with Dyschromatosis symmetrica hereditaria in conjunct with developmental delay]."}, {"pubmed": 38696908, "text": "Exploration and Validation of Ferroptosis-Associated Genes in ADAR1 Deletion-Induced NAFLD through RNA-seq Analysis."}, {"pubmed": 38766853, "text": "Calreticulin regulates the expression of MMP14 and ADAR1 through EIF2AK2 signaling to promote the proliferation and progression of malignant melanoma cells."}, {"pubmed": 38820962, "text": "Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance."}], "genomic_pos": {"chr": "1", "end": 154628013, "ensemblgene": "ENSG00000160710", "start": 154581695, "strand": -1}, "genomic_pos_hg19": {"chr": "1", "end": 154600475, "start": 154554538, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001649", "qualifier": "involved_in", "term": "osteoblast differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002244", "qualifier": "involved_in", "term": "hematopoietic progenitor cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002566", "qualifier": "involved_in", "term": "somatic diversification of immune receptors via somatic mutation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006382", "qualifier": "involved_in", "term": "adenosine to inosine editing"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006382", "pubmed": [15858013, 19651874, 21289159], "qualifier": "involved_in", "term": "adenosine to inosine editing"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006382", "pubmed": 16475990, "qualifier": "involved_in", "term": "adenosine to inosine editing"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006396", "qualifier": "involved_in", "term": "RNA processing"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006397", "qualifier": "involved_in", "term": "mRNA processing"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0009615", "pubmed": 15858013, "qualifier": "involved_in", "term": "response to virus"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0016553", "pubmed": 9020165, "qualifier": "acts_upstream_of_or_within", "term": "base conversion or substitution editing"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030218", "qualifier": "involved_in", "term": "erythrocyte differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0031054", "pubmed": 23622242, "qualifier": "acts_upstream_of_or_within", "term": "pre-miRNA processing"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035455", "pubmed": 16475990, "qualifier": "involved_in", "term": "response to interferon-alpha"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0044387", "pubmed": 19651874, "qualifier": "involved_in", "term": "negative regulation of protein kinase activity by regulation of protein phosphorylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0044387", "pubmed": 18362360, "qualifier": "involved_in", "term": "negative regulation of protein kinase activity by regulation of protein phosphorylation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045070", "pubmed": 19651874, "qualifier": "involved_in", "term": "positive regulation of viral genome replication"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045070", "pubmed": 18362360, "qualifier": "involved_in", "term": "positive regulation of viral genome replication"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0045087", "pubmed": 16475990, "qualifier": "involved_in", "term": "innate immune response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051607", "qualifier": "involved_in", "term": "defense response to virus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060216", "qualifier": "involved_in", "term": "definitive hemopoiesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060339", "qualifier": "involved_in", "term": "negative regulation of type I interferon-mediated signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061484", "qualifier": "involved_in", "term": "hematopoietic stem cell homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070922", "pubmed": 23622242, "qualifier": "acts_upstream_of_or_within", "term": "RISC complex assembly"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0097284", "qualifier": "involved_in", "term": "hepatocyte apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0098586", "qualifier": "involved_in", "term": "cellular response to virus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1900369", "qualifier": "involved_in", "term": "negative regulation of post-transcriptional gene silencing by regulatory ncRNA"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1903944", "qualifier": "involved_in", "term": "negative regulation of hepatocyte apoptotic process"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": [18362360, 23622242], "qualifier": "located_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005634", "pubmed": 7565688, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005730", "qualifier": "is_active_in", "term": "nucleolus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005730", "qualifier": "located_in", "term": "nucleolus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 23622242, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005737", "pubmed": 7565688, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 19946888, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0044530", "pubmed": 18362360, "qualifier": "part_of", "term": "supraspliceosomal complex"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0003677", "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "HDA", "id": "GO:0003723", "pubmed": [22658674, 22681889], "qualifier": "enables", "term": "RNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0003725", "qualifier": "enables", "term": "double-stranded RNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0003726", "qualifier": "enables", "term": "double-stranded RNA adenosine deaminase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003726", "pubmed": 9020165, "qualifier": "enables", "term": "double-stranded RNA adenosine deaminase activity"}, {"category": "MF", "evidence": "NAS", "id": "GO:0003726", "pubmed": 7565688, "qualifier": "enables", "term": "double-stranded RNA adenosine deaminase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [18362360, 22810585, 23853584, 24136289, 28355180, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008251", "qualifier": "enables", "term": "tRNA-specific adenosine deaminase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}]}, "homologene": {"genes": [[7955, 58119], [8364, 100493195], [9031, 769675], [9544, 718759], [9598, 457349], [9606, 103], [9615, 100855668], [9913, 505134], [10090, 56417], [10116, 81635]], "id": 9281}, "interpro": [{"desc": "Adenosine deaminase/editase", "id": "IPR002466", "short_desc": "A_deamin"}, {"desc": "Double-stranded RNA-binding domain", "id": "IPR014720", "short_desc": "dsRBD_dom"}, {"desc": "Winged helix-like DNA-binding domain superfamily", "id": "IPR036388", "short_desc": "WH-like_DNA-bd_sf"}, {"desc": "Winged helix DNA-binding domain superfamily", "id": "IPR036390", "short_desc": "WH_DNA-bd_sf"}, {"desc": "Z-binding domain", "id": "IPR042371", "short_desc": "Z_dom"}, {"desc": "ADAR1, first double-stranded RNA binding domain", "id": "IPR044456", "short_desc": "ADAR1_DSRM_1"}, {"desc": "ADAR1, third double-stranded RNA binding domain", "id": "IPR044457", "short_desc": "ADAR1_DSRM_3"}], "ipi": ["IPI00025057", "IPI00025058", "IPI00394665", "IPI00394668", "IPI00760588", "IPI00978400"], "map_location": "1q21.3", "name": "adenosine deaminase RNA specific", "other_names": ["136 kDa double-stranded RNA-binding protein", "adenosine deaminase acting on RNA 1-A", "double-stranded RNA-specific adenosine deaminase", "dsRNA adenosine deaminase", "dsRNA adeonosine deaminase", "interferon-induced protein 4", "interferon-inducible protein 4"], "pantherdb": {"HGNC": "225", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1889575", "ortholog_type": "LDO", "panther_family": "PTHR10910", "taxid": 10090, "uniprot_kb": "Q99MU3"}, {"RGD": "71099", "ortholog_type": "LDO", "panther_family": "PTHR10910", "taxid": 10116, "uniprot_kb": "P55266"}, {"Ensembl": "ENSGALG00000021475", "ortholog_type": "LDO", "panther_family": "PTHR10910", "taxid": 9031, "uniprot_kb": "A0A1D6Y7R2"}, {"ZFIN": "ZDB-GENE-000616-5", "ortholog_type": "LDO", "panther_family": "PTHR10910", "taxid": 7955, "uniprot_kb": "E9QIW2"}, {"TAIR": "2198185", "ortholog_type": "LDO", "panther_family": "PTHR10910", "taxid": 3702, "uniprot_kb": "F4HU58"}], "uniprot_kb": "P55265"}, "pathway": {"biocarta": {"id": "antisensepathway", "name": "antisense pathway"}, "kegg": [{"id": "hsa04623", "name": "Cytosolic DNA-sensing pathway - Homo sapiens (human)"}, {"id": "hsa05162", "name": "Measles - Homo sapiens (human)"}, {"id": "hsa05164", "name": "Influenza A - Homo sapiens (human)"}, {"id": "hsa05171", "name": "Coronavirus disease - COVID-19 - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1169410", "name": "Antiviral mechanism by IFN-stimulated genes"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-75064", "name": "mRNA Editing: A to I Conversion"}, {"id": "R-HSA-75072", "name": "mRNA Editing"}, {"id": "R-HSA-75102", "name": "C6 deamination of adenosine"}, {"id": "R-HSA-77042", "name": "Formation of editosomes by ADAR proteins"}, {"id": "R-HSA-8953854", "name": "Metabolism of RNA"}, {"id": "R-HSA-909733", "name": "Interferon alpha/beta signaling"}, {"id": "R-HSA-913531", "name": "Interferon Signaling"}, {"id": "R-HSA-9833482", "name": "PKR-mediated signaling"}], "wikipathways": {"id": "WP4655", "name": "Cytosolic DNA-sensing pathway"}}, "pdb": ["1QBJ", "1QGP", "1XMK", "2ACJ", "2GXB", "2L54", "2MDR", "3F21", "3F22", "3F23", "3IRQ", "3IRR", "5ZU1", "5ZUO", "5ZUP", "7C0I", "7ZJ1", "7ZLQ", "8GBC", "8GBD"], "pfam": ["PF00035", "PF02137", "PF02295"], "pharmgkb": "PA24555", "pharos": {"target_id": 14362, "tdl": "Tbio"}, "pir": "S65593", "prosite": ["PS50137", "PS50139", "PS50141"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF245331", "relationship": "is"}, {"id": "GNF245332", "relationship": "is"}, {"id": "GNF245333", "relationship": "is"}, {"id": "GNF245334", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF038900", "relationship": "similar to"}, {"id": "GNF046539", "relationship": "is"}, {"id": "GNF050305", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF000223", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF098323", "relationship": "is"}, {"id": "GNF137978", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_011844.2"], "protein": ["NP_001020278.1", "NP_001102.3", "NP_001180424.1", "NP_001351974.1", "NP_001351975.1", "NP_001351976.1", "NP_001351977.1", "NP_001351978.1", "NP_056655.3", "NP_056656.3", "XP_011507363.2", "XP_011507364.1", "XP_047284296.1", "XP_047284342.1", "XP_047284361.1", "XP_047284397.1", "XP_054189776.1", "XP_054189777.1", "XP_054189778.1", "XP_054189779.1", "XP_054189780.1", "XP_054189781.1"], "rna": ["NM_001025107.3", "NM_001111.5", "NM_001193495.2", "NM_001365045.1", "NM_001365046.1", "NM_001365047.1", "NM_001365048.1", "NM_001365049.1", "NM_015840.4", "NM_015841.4", "XM_011509061.3", "XM_011509062.2", "XM_047428340.1", "XM_047428386.1", "XM_047428405.1", "XM_047428441.1", "XM_054333801.1", "XM_054333802.1", "XM_054333803.1", "XM_054333804.1", "XM_054333805.1", "XM_054333806.1"], "translation": [{"protein": "XP_011507364.1", "rna": "XM_011509062.2"}, {"protein": "XP_047284296.1", "rna": "XM_047428340.1"}, {"protein": "XP_054189776.1", "rna": "XM_054333801.1"}, {"protein": "XP_054189779.1", "rna": "XM_054333804.1"}, {"protein": "XP_054189780.1", "rna": "XM_054333805.1"}, {"protein": "NP_001102.3", "rna": "NM_001111.5"}, {"protein": "NP_001180424.1", "rna": "NM_001193495.2"}, {"protein": "XP_011507363.2", "rna": "XM_011509061.3"}, {"protein": "NP_001351974.1", "rna": "NM_001365045.1"}, {"protein": "NP_056655.3", "rna": "NM_015840.4"}, {"protein": "NP_001351978.1", "rna": "NM_001365049.1"}, {"protein": "XP_054189778.1", "rna": "XM_054333803.1"}, {"protein": "NP_001351977.1", "rna": "NM_001365048.1"}, {"protein": "XP_047284342.1", "rna": "XM_047428386.1"}, {"protein": "XP_054189781.1", "rna": "XM_054333806.1"}, {"protein": "NP_001351975.1", "rna": "NM_001365046.1"}, {"protein": "NP_001020278.1", "rna": "NM_001025107.3"}, {"protein": "NP_001351976.1", "rna": "NM_001365047.1"}, {"protein": "XP_047284397.1", "rna": "XM_047428441.1"}, {"protein": "NP_056656.3", "rna": "NM_015841.4"}, {"protein": "XP_054189777.1", "rna": "XM_054333802.1"}, {"protein": "XP_047284361.1", "rna": "XM_047428405.1"}]}, "reporter": {"HG-U133_Plus_2": "201786_s_at", "HG-U95Av2": "38014_at", "HTA-2_0": "TC01003295.hg.1", "HuEx-1_0": ["2436754", "3045861", "3440646"], "HuGene-1_1": "7920531", "HuGene-2_1": "16693813"}, "retired": 3427, "summary": "This gene encodes the enzyme responsible for RNA editing by site-specific deamination of adenosines. This enzyme destabilizes double-stranded RNA through conversion of adenosine to inosine. Mutations in this gene have been associated with dyschromatosis symmetrica hereditaria. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2010].", "symbol": "ADAR", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412215"}, "unigene": "Hs.12341", "uniprot": {"Swiss-Prot": "P55265", "TrEMBL": ["A0A7P0TA14", "A2IBT1", "A0A3B3ISX1", "A0A3B3ITG9", "A0A7P0Z4F9", "A0AAG2U5V6", "A0A7P0Z4K3", "A0AAG2TPR9", "A0AAG2U823", "A0A3B3ISU1", "A0AAG2TPY2"]}, "wikipedia": {"url_stub": "ADAR"}}